This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Stephanie Louise Ciesla
Introduction
Stephanie Louise Ciesla is a notable inventor based in Morristown, NJ (US). She has made significant contributions to the field of pharmacology, particularly through her innovative work on adrenergic receptor agonists. Her research has the potential to impact various medical treatments and therapeutic approaches.
Latest Patents
Ciesla holds one patent titled "Functionally selective alpha2C adrenoreceptor agonists." This invention presents a novel class of biaryl compounds that serve as inhibitors of alpha2C adrenergic receptor agonists. The patent outlines methods for preparing these compounds, pharmaceutical compositions that include them, and various methods for treatment, prevention, inhibition, or amelioration of conditions associated with the alpha2C adrenergic receptors.
Career Highlights
Stephanie is currently associated with Merck Sharp & Dohme Corporation, where she continues to advance her research and development efforts. Her work at Merck has allowed her to contribute to significant advancements in pharmaceutical sciences.
Collaborations
Ciesla has collaborated with esteemed colleagues, including Manuel De Lera Ruiz and Kevin D McCormick. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Stephanie Louise Ciesla exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and collaborative efforts highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile